FI845036L - Inotropiska kinolonderivat. - Google Patents

Inotropiska kinolonderivat.

Info

Publication number: FI845036L
Authority: FI; Finland
Prior art keywords: kinolonderivat; inotropic; inotropic kinolonderivat
Prior art date: 1983-12-22

Application number

FI845036A

Other languages

English (en)

Finnish (fi)

Other versions

FI845036A0 (fi

FI845036A7 (fi

Inventor

David Anthony Roberts

Simon Fraser Campbell

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1983-12-22

Filing date

1984-12-19

Publication date

1985-06-23

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26287130&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI845036(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1983-12-22 Priority claimed from GB838334282A external-priority patent/GB8334282D0/en

1984-07-06 Priority claimed from GB848417340A external-priority patent/GB8417340D0/en

1984-12-19 Application filed by Pfizer filed Critical Pfizer

1984-12-19 Publication of FI845036A0 publication Critical patent/FI845036A0/fi

1985-06-23 Publication of FI845036A7 publication Critical patent/FI845036A7/fi

1985-06-23 Publication of FI845036L publication Critical patent/FI845036L/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
- C07D215/28—Alcohols; Ethers thereof with halogen atoms or nitro radicals in positions 5, 6 or 7
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Cardiology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Hospice & Palliative Care (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Heart & Thoracic Surgery (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Plural Heterocyclic Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

FI845036A 1983-12-22 1984-12-19 Inotropiska kinolonderivat. FI845036L (fi)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB838334282A GB8334282D0 (en)	1983-12-22	1983-12-22	Quinolone inotropic agents
GB848417340A GB8417340D0 (en)	1984-07-06	1984-07-06	Quinoline inotropic agents

Publications (3)

Publication Number	Publication Date
FI845036A0 FI845036A0 (fi)	1984-12-19
FI845036A7 FI845036A7 (fi)	1985-06-23
FI845036L true FI845036L (fi)	1985-06-23

Family

ID=26287130

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI845036A FI845036L (fi)	1983-12-22	1984-12-19	Inotropiska kinolonderivat.

Country Status (17)

Country	Link
US (1)	US4710507A (es)
EP (1)	EP0148623A3 (es)
KR (1)	KR870000911B1 (es)
AU (1)	AU556494B2 (es)
CA (1)	CA1253497A (es)
CS (1)	CS249533B2 (es)
DK (1)	DK619584A (es)
ES (1)	ES538805A0 (es)
FI (1)	FI845036L (es)
GR (1)	GR82511B (es)
HU (1)	HUT36472A (es)
IL (1)	IL73877A (es)
NO (1)	NO845228L (es)
NZ (1)	NZ210670A (es)
PL (1)	PL144816B1 (es)
PT (1)	PT79699B (es)
SU (1)	SU1407397A3 (es)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PT80533B (en) *	1984-05-29	1987-04-06	Pfizer	Process for preparing quinolone inotropic agents
US4567186A (en) *	1985-01-14	1986-01-28	Sterling Drug Inc.	5-Heteryl-1,6-naphthyridin-2(1H)-ones, cardiotonic use thereof and intermediates therefor
NZ214837A (en) *	1985-01-28	1988-10-28	Sterling Drug Inc	5-substituted 1,6 naphthyridin-2(1h)-ones
GB8502267D0 (en) *	1985-01-30	1985-02-27	Pfizer Ltd	Quinolone inotropic agents
FR2580646A1 (fr) *	1985-04-19	1986-10-24	Synthelabo	Derives de 2(1h)-quinolinone, leur preparation et leur application en therapeutique
GB8516573D0 (en) *	1985-07-01	1985-08-07	Janssen Pharmaceuticaa Nv	Controlling weeds
US4666913A (en) *	1985-11-22	1987-05-19	William H. Rorer, Inc.	Hydroxy and aminothiazolyl-benzodiazinone compounds, cardiotonic compositions including the same, and their uses
GB8529362D0 (en) *	1985-11-28	1986-01-02	Pfizer Ltd	Quinolone cardiac stimulants
DK111387A (da) *	1986-03-05	1987-09-06	Otsuka Pharma Co Ltd	Carbostyrilderivater og salte deraf, laegemiddel indeholdende saadanne derivater samt fremgangsmaade til fremstilling af derivaterne
US5358949A (en) *	1986-03-05	1994-10-25	Otsuka Pharmaceutical Co., Ltd.	Carbostyril derivatives and salts thereof and anti-arrhythmic agents containing the carbostyril derivatives
US4921862A (en) *	1986-05-29	1990-05-01	Syntex (U.S.A.) Inc.	Carbostyril derivatives as combined thromboxane synthetase and cyclic-amp phosphodiesterase inhibitors
US4792561A (en) *	1986-05-29	1988-12-20	Syntex (U.S.A.) Inc.	Carbostyril derivatives as combined thromboxane synthetase and cyclic-AMP phosphodiesterase inhibitors
US4785005A (en) *	1986-06-25	1988-11-15	Rorer Pharmaceutical Corporation	6-(6-alkylpyridone)-carbostyril compounds and their cardiotonic uses
GB8619902D0 (en) *	1986-08-15	1986-09-24	Pfizer Ltd	Quinolone cardiac stimulants
US4859672A (en) *	1986-10-29	1989-08-22	Rorer Pharmaceutical Corporation	Pyrido[2,3-d]pyrimidinone and imidazo[4,5-b]pyrimidinone
US5002944A (en) *	1986-10-29	1991-03-26	Rhone-Poulenc Rorer Pharmaceuticals Inc.	Compounds having cardiotonic activity
US5166160A (en) *	1986-12-23	1992-11-24	Burroughs Wellcome Co.	Quinoline compound
GB8630702D0 (en) *	1986-12-23	1987-02-04	Wellcome Found	Quinoline compound
GB8709448D0 (en) *	1987-04-21	1987-05-28	Pfizer Ltd	Heterobicyclic quinoline derivatives
DE3935514A1 (de) *	1989-10-25	1991-05-02	Boehringer Mannheim Gmbh	Neue bicyclo-imidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
WO1992004327A1 (en) *	1990-09-07	1992-03-19	Schering Corporation	Antiviral compounds and antihypertensive compounds
HU207308B (en) *	1990-11-09	1993-03-29	Richter Gedeon Vegyeszet	Process for producing 1- /2-/5-/dimethyl-amino-methyl/-2-/furyl-methyl-thio/-ethyl//- -amino-1-/methyl-amino-2-nitro-ethylene
US5141931A (en) *	1991-01-03	1992-08-25	Sterling Winthrop Inc.	5-Quinolinylpyridinones, cardiotonic compositions and methods
GB9200781D0 (en) *	1992-01-15	1992-03-11	Merck Sharp & Dohme	Therapeutic agents
JP2686887B2 (ja) *	1992-08-11	1997-12-08	キッセイ薬品工業株式会社	ピペリジノ−３，４−ジヒドロカルボスチリル誘導体
FR2703681B1 (fr) *	1993-04-08	1995-05-12	Bellon Labor Sa Roger	Procede de preparation de fluoro-6-halogeno-2 quinoleine
JP2000256323A (ja)	1999-01-08	2000-09-19	Japan Tobacco Inc	２−オキソキノリン化合物及びその医薬用途
KR20020038741A (ko)	1999-08-27	2002-05-23	윌리암 엘. 레스페스	안드로겐 수용체 조절 화합물 및 방법
US6566372B1 (en) *	1999-08-27	2003-05-20	Ligand Pharmaceuticals Incorporated	Bicyclic androgen and progesterone receptor modulator compounds and methods
US6667313B1 (en)	1999-08-27	2003-12-23	Ligand Pharmaceuticals Inc.	8-substituted-6-triflouromethyl-9-pyrido [3,2-G] quinoline compounds as androgen receptor modulators
JP2003529545A (ja)	1999-09-14	2003-10-07	リガンド・ファーマシューティカルズ・インコーポレイテッド	改善された薬理学的プロファイルを有するｒｘｒモジュレーター
WO2002081728A2 (en) *	2001-04-06	2002-10-17	Smithkline Beecham Corporation	Quinoline inhibitors of hyak1 and hyak3 kinases
UA79293C2 (en) *	2002-07-03	2007-06-11	Univ Wayne State	4-(7'-halo-2-quino (xa-) linyloxy)phenoxy propionic acid derivatives as antineoplastic agents
BRPI0406778A (pt)	2003-01-17	2006-01-17	Warner Lambert Co	Antagonistas de receptores de androgênio
JP2006517976A (ja) *	2003-02-14	2006-08-03	スミスクライン・ビーチャム・コーポレイション	新規化合物
CA2536349A1 (en) *	2003-08-22	2005-03-03	Ligand Pharmaceuticals Incorporated	6-cycloamino-2-quinolinone derivatives as androgen receptor modulator compounds
CL2008000838A1 (es)	2007-03-23	2008-10-10	Neuraxon Inc	Compuestos derivados de quinolina y tetrahidroquinolina, con actividad inhibidora nos; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar un dolor de cabeza tal como migrana, dolor cronico, desordenes del sistema nervios
DE102008022221A1 (de) *	2008-05-06	2009-11-12	Universität des Saarlandes	Inhibitoren der humanen Aldosteronsynthase CYP11B2
US8541404B2 (en)	2009-11-09	2013-09-24	Elexopharm Gmbh	Inhibitors of the human aldosterone synthase CYP11B2
ES2763332T3 (es) *	2011-09-15	2020-05-28	Hoffmann La Roche	Nuevos derivados de dihidroquinolin-2-ona
DK2785695T3 (da)	2011-11-30	2020-08-24	Fhoffmann-La Roche Ag	Nye bicykliske dihydroisoquinolin-1-on-derivater
CA2888485C (en)	2012-10-16	2021-01-26	Janssen Pharmaceutica Nv	Phenyl linked quinolinyl modulators of ror.gamma.t
ME02794B (me)	2012-10-16	2018-01-20	Janssen Pharmaceutica Nv	Metilen vezani hinolinil modulatori ror-gama-t
AU2013331493A1 (en)	2012-10-16	2015-04-09	Janssen Pharmaceutica Nv	Heteroaryl linked quinolinyl modulators of RORyt
MX2015010611A (es)	2013-03-08	2015-12-16	Hoffmann La Roche	Nuevos derivados de dihidroquinolin-2-ona como inhibidores de la aldosterona-sintasa (citocromo p450, familia 11, subfamilia b, polipeptido 2 (cyp11b2) o citocromo p450, familia 11, subfamilia b, polipeptido 1 (cyp11b1)).
LT3004077T (lt) *	2013-05-27	2020-01-27	F. Hoffmann-La Roche Ag	Nauji 3,4-dihidro-2h-izochinolin-1-ono ir 2,3-dihidro-izoindol-1-ono junginiai
US9284308B2 (en)	2013-10-15	2016-03-15	Janssen Pharmaceutica Nv	Methylene linked quinolinyl modulators of RORγt
US9328095B2 (en)	2013-10-15	2016-05-03	Janssen Pharmaceutica Nv	Heteroaryl linked quinolinyl modulators of RORgammat
US9403816B2 (en)	2013-10-15	2016-08-02	Janssen Pharmaceutica Nv	Phenyl linked quinolinyl modulators of RORγt
BR112016008215A2 (pt)	2013-10-15	2017-09-26	Janssen Pharmaceutica Nv	moduladores de quinolinila ligados por alquila de roryt
US9221804B2 (en)	2013-10-15	2015-12-29	Janssen Pharmaceutica Nv	Secondary alcohol quinolinyl modulators of RORγt
US10555941B2 (en)	2013-10-15	2020-02-11	Janssen Pharmaceutica Nv	Alkyl linked quinolinyl modulators of RORγt
ES2742843T3 (es)	2013-10-15	2020-02-17	Janssen Pharmaceutica Nv	Moduladores de quinolinilo de ROR(gamma)t
CN115504933B (zh) *	2022-10-13	2024-12-13	深圳万知达企业管理有限公司	一种多取代喹啉酮化合物的制备方法及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3907808A (en) *	1971-05-17	1975-09-23	Sterling Drug Inc	1,4-Dihydro-4-oxo-7-pyridyl-3-quinolinecarboxylic acid derivatives
US3962445A (en) *	1973-05-19	1976-06-08	Beecham Group Limited	Anti-allergenic carbostyril derivatives
US3993656A (en) *	1974-11-19	1976-11-23	Merck & Co., Inc.	1,8-Naphthyridine compounds
JPS5473783A (en) *	1977-11-15	1979-06-13	Otsuka Pharmaceut Co Ltd	Pyridine derivative
US4258185A (en) *	1978-10-17	1981-03-24	Yoshitomi Pharmaceutical Industries, Ltd.	Pyridazinone compounds
FR2439196A1 (fr) *	1978-10-17	1980-05-16	Yoshitomi Pharmaceutical	Nouveaux derives de la pyridazinone utilisables en therapeutique comme agents anti-thrombotiques et anti-hypertenseurs
JPS5777676A (en) *	1980-10-31	1982-05-15	Otsuka Pharmaceut Co Ltd	Carbostyril derivative
CA1164459A (en) *	1980-11-11	1984-03-27	Yung-Hsiung Yang	Process for preparing (imidazo¬1,2-a\|pyridine- 2-yl)-carbostyril or -3,4-dihydrocarbostyryl derivatives
EP0102046A1 (en) *	1982-08-26	1984-03-07	Schering Corporation	Tricyclic lactams, method for making them, pharmaceutical compositions containing them

1984
- 1984-12-18 US US06/683,440 patent/US4710507A/en not_active Expired - Lifetime
- 1984-12-18 PT PT79699A patent/PT79699B/pt unknown
- 1984-12-19 EP EP84308925A patent/EP0148623A3/en not_active Withdrawn
- 1984-12-19 ES ES538805A patent/ES538805A0/es active Granted
- 1984-12-19 CS CS8410000A patent/CS249533B2/cs unknown
- 1984-12-19 GR GR82511A patent/GR82511B/el unknown
- 1984-12-19 FI FI845036A patent/FI845036L/fi not_active Application Discontinuation
- 1984-12-20 IL IL73877A patent/IL73877A/xx unknown
- 1984-12-20 PL PL1984251092A patent/PL144816B1/pl unknown
- 1984-12-20 CA CA000470605A patent/CA1253497A/en not_active Expired
- 1984-12-20 NZ NZ210670A patent/NZ210670A/en unknown
- 1984-12-21 HU HU844800A patent/HUT36472A/hu unknown
- 1984-12-21 SU SU843826174A patent/SU1407397A3/ru active
- 1984-12-21 AU AU37017/84A patent/AU556494B2/en not_active Ceased
- 1984-12-21 DK DK619584A patent/DK619584A/da not_active Application Discontinuation
- 1984-12-21 NO NO845228A patent/NO845228L/no unknown
- 1984-12-21 KR KR1019840008229A patent/KR870000911B1/ko not_active Expired

Also Published As

Publication number	Publication date
KR870000911B1 (ko)	1987-05-06
SU1407397A3 (ru)	1988-06-30
PT79699A (en)	1985-01-01
IL73877A (en)	1988-10-31
FI845036A0 (fi)	1984-12-19
PL144816B1 (en)	1988-07-30
HUT36472A (en)	1985-09-30
EP0148623A2 (en)	1985-07-17
IL73877A0 (en)	1985-03-31
DK619584A (da)	1985-06-23
AU556494B2 (en)	1986-11-06
FI845036A7 (fi)	1985-06-23
ES8603863A1 (es)	1986-01-01
DK619584D0 (da)	1984-12-21
PL251092A1 (en)	1985-12-17
CA1253497A (en)	1989-05-02
KR850004478A (ko)	1985-07-15
PT79699B (en)	1986-12-10
CS249533B2 (en)	1987-03-12
NZ210670A (en)	1987-03-31
NO845228L (no)	1985-06-24
AU3701784A (en)	1985-07-04
US4710507A (en)	1987-12-01
ES538805A0 (es)	1986-01-01
GR82511B (en)	1985-04-22
EP0148623A3 (en)	1986-06-04

Publication	Publication Date	Title
FI845036L (fi)	1985-06-23	Inotropiska kinolonderivat.
DE3484505D1 (de)	1991-05-29	Immuntest.
DE3486259D1 (de)	1994-02-10	Carboxyalkenamidocephalosporine.
FI841548A0 (fi)	1984-04-18	Fenetanolaminderivat.
EP0136362A4 (en)	1988-01-07	Biosensor.
FI81916B (fi)	1990-08-31	Foer straolning kaenslig skiva.
DE3481389D1 (de)	1990-03-29	Mikrorechner.
FI844087A0 (fi)	1984-10-17	Katodstraoleroer-displayanordning.
FI841708A0 (fi)	1984-04-30	Bleknings- och rengoeringsblandning.
FI844017L (fi)	1985-04-14	Biolyminescensutnyttjande immunologisk haltbestaemning.
FI833835L (fi)	1984-11-05	Stoppverktygsenhet foer en flyttbar skenlaeggningsmaskin.
FI831194L (fi)	1984-10-09	Nappflaska.
FI843892L (fi)	1985-04-05	Nytt roerlaos.
FI840386L (fi)	1984-08-02	Monteringsanordning foer omvandlare.
FI840604L (fi)	1984-08-17	Antifungicida triazolfoereningar.
FI844998A0 (fi)	1984-12-18	Formningsenhet foer dubbelvirapappersmaskin.
FI834486L (fi)	1984-08-04	Kontinuerligt verkande motstroemsbaelttvaettare.
FI844688A0 (fi)	1984-11-29	Litiummaol.
FI841482A0 (fi)	1984-04-13	Visarinstrument.
DE3483137D1 (de)	1990-10-11	Ec-torfeld.
FI842444A7 (fi)	1984-12-17	Spolanordning foer spannmjoelkningsanlaeggningar.
FI834696L (fi)	1985-02-23	Teleskopuppbyggd stativpelare.
FI834415A7 (fi)	1985-06-03	Borrstyrning- flaensbildningsanordning.
FI841507A0 (fi)	1984-04-16	Tunnskaligt formstycke.
FI844089A0 (fi)	1984-10-17	Elkopplare.

Legal Events

Date	Code	Title	Description
2004-08-31	FA	Application withdrawn [patent]	Owner name: PFIZER CORPORATION